. Author manuscript; available in PMC: 2015 Jan 1.

Published in final edited form as: J Pediatr. 2013 Aug 27;164(1):34–39.e2. doi: 10.1016/j.jpeds.2013.07.027

Table 6. Growth at 18 to 22 months according to treatment assignment (adjusted analysis).

Variable	Dexamethasone n=76	Placebo n=68	RR (95% CI)	P-value
Male – no. (%)	38(50)	33(49)		0.86
Clinical steroid use – no. (%)	28(37)	39(57)		0.01
Growth parameters	Mean ± S.D
Weight – kg.	10.3±1.6	10.3±1.4		0.98
Length – cm.	80.3±4.9	80.0±4.2		0.60
Head circumference - cm	46.8±2.2	46.6±2.1^**		0.59
Growth < 10^th percentile
Weight – no. (%)	38(50)	27(40)	1.16(0.81,1.66)	0.42
Length - no. (%)^*	19(25)	21(31)	0.76(0.45,1.27)	0.29
Head circumference – no. (%)^*	21(28)	19(28)^**	0.96(0.57,1.63)	0.88

RR is the relative risk of the outcome in the dexamethasone group as compared with the placebo group. CI denotes confidence interval.

Not adjusted for center because of convergence issues.

^**

In the placebo group, n=67 for head circumference